BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 17465868)

  • 1. Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia.
    Ronga G; Bruno R; Puxeddu E; Calcinaro F; Montesano T; Travascio L; Colandrea M; Durante C; Maranghi M; Filetti S; Russo D
    Thyroid; 2007 Apr; 17(4):363-6. PubMed ID: 17465868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.
    Salvatore B; Paone G; Klain M; Storto G; Nicolai E; D'Amico D; Della Morte AM; Pace L; Salvatore M
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):2-8. PubMed ID: 17538522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma.
    Berger F; Unterholzner S; Diebold J; Knesewitsch P; Hahn K; Spitzweg C
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1258-63. PubMed ID: 16982034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine breast uptake in nonbreastfeeding women: clinical and scintigraphic characteristics.
    Hammami MM; Bakheet S
    J Nucl Med; 1996 Jan; 37(1):26-31. PubMed ID: 8543996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake.
    Castro MR; Bergert ER; Goellner JR; Hay ID; Morris JC
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5627-32. PubMed ID: 11701745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioiodine uptake in a renal cyst mimicking a metastasis in a patient affected by differentiated thyroid cancer: case report and review of the literature.
    Campennì A; Ruggeri RM; Giovinazzo S; Sindoni A; Santoro D; Baldari S
    Ann Nucl Med; 2014 Jun; 28(5):472-6. PubMed ID: 24554089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine treatment with 30 mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for postsurgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation.
    Barbaro D; Boni G; Meucci G; Simi U; Lapi P; Orsini P; Pasquini C; Piazza F; Caciagli M; Mariani G
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4110-5. PubMed ID: 12970272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing and potential role of diagnostic I-123 scintigraphy in assessing radioiodine breast uptake before ablation in postpartum women with thyroid cancer: a case series.
    Brzozowska M; Roach PJ
    Clin Nucl Med; 2006 Nov; 31(11):683-7. PubMed ID: 17053384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral breast uptake of radioiodine in a male patient with gynecomastia: A case report.
    Uslu L; Ozbayrak M; Vatankulu B; Sonmezoglu K
    Indian J Nucl Med; 2015; 30(4):345-6. PubMed ID: 26430322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosiglitazone effect on radioiodine uptake in thyroid carcinoma patients with high thyroglobulin but negative total body scan: a correlation with the expression of peroxisome proliferator-activated receptor-gamma.
    Tepmongkol S; Keelawat S; Honsawek S; Ruangvejvorachai P
    Thyroid; 2008 Jul; 18(7):697-704. PubMed ID: 18630997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma.
    Luster M; Lassmann M; Haenscheid H; Michalowski U; Incerti C; Reiners C
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3640-5. PubMed ID: 11061516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of radioiodine uptake by the lactating breast.
    Bakheet SM; Hammami MM
    Eur J Nucl Med; 1994 Jul; 21(7):604-8. PubMed ID: 7957345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioiodine therapy for thyroid cancer].
    Misaki T
    Nihon Rinsho; 2007 Nov; 65(11):2049-52. PubMed ID: 18018569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
    Mazzaferri EL; Kloos RT
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of risperidone-induced hyperprolactinemia with a dopamine agonist in children.
    Cohen LG; Biederman J
    J Child Adolesc Psychopharmacol; 2001; 11(4):435-40. PubMed ID: 11838826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy.
    Kaptein EM; Levenson H; Siegel ME; Gadallah M; Akmal M
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3058-64. PubMed ID: 10999786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of diffuse hepatic uptake observed in postablative and post-therapeutic I-131 scans.
    Omür O; Akgün A; Ozcan Z; Sen C; OzkiIiç H
    Clin Nucl Med; 2009 Jan; 34(1):11-4. PubMed ID: 19092374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.